Back

Sphingosine-1-phosphate reduces arterial thrombosis via enhanced endothelial thrombomodulin expression by S1PR1 signaling

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Platelets and thrombosis: novel experimental aspects Platelets, Haemostasis, Coagulation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Marcel Benkhoff

University Hospital Duesseldorf, Duesseldorf (Germany)

4 More presentations in this session

Presentation thumbnail
The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia.
Mr T. Pirker (Christchurch, NZ)
Abstract Slides Video
Presentation thumbnail
Single-cell mass cytometry analysis unveils prothrombotic expression and heterogeneity in essential thrombocythemia
Doctor S. Kuehne (Augsburg, DE)
Abstract Slides Video
Presentation thumbnail
Thrombin generation, fibrin clot permeation and lysis in patients with severe mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair: mitral fibrin study.
Doctor A. Siniarski (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Direct IL-6 inhibition prevents arterial thrombosis by reducing collagen-mediated platelets activation
Doctor S. Ministrini (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Platelets and thrombosis: novel experimental aspects

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Role of platelet derived sphingosine-1-phosphate in thrombosis and vascular ageing
thumbnail
Congress Presentation
HFWM: impact of Sphingosine Kinase 1 and S1P signaling in post-ischemic cardiomyocytes
thumbnail
Congress Presentation
Tgfb increases platelet PAR4 expression to exacerbate thrombotic risk in hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources